VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 71 filers reported holding VERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,343 | -11.4% | 16,874 | +3.7% | 0.00% | -50.0% |
| Q2 2023 | $261,214 | +221.3% | 16,275 | +55.4% | 0.00% | +100.0% |
| Q1 2023 | $81,294 | -38.0% | 10,476 | +54.6% | 0.00% | 0.0% |
| Q4 2022 | $131,154 | -7.6% | 6,778 | +1.9% | 0.00% | 0.0% |
| Q3 2022 | $142,000 | +61.4% | 6,651 | +2.5% | 0.00% | 0.0% |
| Q2 2022 | $88,000 | -45.0% | 6,488 | -4.5% | 0.00% | 0.0% |
| Q1 2022 | $160,000 | +13.5% | 6,794 | +29.2% | 0.00% | 0.0% |
| Q4 2021 | $141,000 | +110.4% | 5,259 | +36.0% | 0.00% | – |
| Q3 2021 | $67,000 | – | 3,867 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $87,472,500 | 9.83% |
| Kynam Capital Management, LP | 3,000,000 | $48,150,000 | 6.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 975,227 | $15,642,641 | 4.76% |
| Sofinnova Investments, Inc. | 3,467,156 | $55,647,854 | 3.64% |
| Eversept Partners, LP | 1,740,951 | $27,942,264 | 2.34% |
| Altium Capital Management LP | 120,000 | $1,926,000 | 1.46% |
| Carlyle Group Inc. | 2,416,837 | $38,766,065 | 1.38% |
| SECTORAL ASSET MANAGEMENT INC | 351,646 | $5,643,918 | 0.94% |
| Tri Locum Partners LP | 108,928 | $1,748,294 | 0.65% |
| Orbimed Advisors | 1,756,800 | $28,196,640 | 0.51% |